62 active trials 33 recruiting 15 Phase 3 17 disease areas 5 changes in 30 days
4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.
Recruitment opened
Also in this update: Interventions modified
Innovent Biologics (Suzhou) Co. Ltd.Phase 3 NCT07623798 Registry history of NCT07623798 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Innovent Biologics (Suzhou) Co. Ltd.Phase 2 NCT06862908 Registry history of NCT06862908 on ClinicalTrials.gov (opens the registry)
Updated
Trial status changed: Not Yet Recruiting → Active, Not Recruiting
Innovent Biologics (Suzhou) Co. Ltd.Phase 2 NCT07352969 Registry history of NCT07352969 on ClinicalTrials.gov (opens the registry)
Updated
Trial status changed: Not Yet Recruiting → Active, Not Recruiting
Innovent Biologics (Suzhou) Co. Ltd.Phase 1 NCT07556796 Registry history of NCT07556796 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-25 | NCT07842497 A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty Arthritis | Phase 2 | Not Yet Recruiting |
| 2026-09-24 | NCT07838220 A Study of IBI3016 in Japanese Participants | Phase 1 | Recruiting |
| 2026-09-23 | NCT07836660 A Study of IBI355 in Participants With Moderate-to-Severe Sjögren's Disease | Phase 2 | Not Yet Recruiting |
| Phase 1 | 21 | |
| Phase 1/2 | 6 | |
| Phase 2 | 17 | |
| Phase 3 | 15 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07265258 | A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease | Thyroid Eye Disease | Recruiting | 2026-08-13 |
| Phase 3 | ||||
| NCT07066098 | A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously… | Pancreatic Cancer | Recruiting | 2026-10-05 |
| NCT07623798 | A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 | Relapsed or Refractory Multiple Myeloma | Recruiting | 2026-09-17 |
| NCT07722494 | IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer | Colorectal Cancer | Recruiting | 2026-08-10 |
| NCT07469800 | Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity | Overweight | Recruiting | 2026-05-27 |
| NCT07255209 | A Study of IBI362 in Chinese Adolescents With Obesity or Overweight | Adolescents With Obesity or Overweight With Weight-Related Comorbidities | Recruiting | 2026-01-08 |
| NCT07113262 | A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive… | Thyroid Eye Disease | Recruiting | 2025-11-17 |
| NCT06931028 | A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 | Sleep Apnea | Recruiting | 2025-06-29 |
| NCT06834672 | Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With… | Ovarian | Active, Not Recruiting | 2026-09-09 |
| NCT07473960 | IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia | Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia | Active, Not Recruiting | 2026-08-14 |
| NCT07754786 | A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants… | Atopic Dermatitis | Not Yet Recruiting | 2026-08-10 |
| NCT05890742 | A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With… | MSI-H | Active, Not Recruiting | 2026-05-28 |
| NCT06238843 | A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's… | Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Active, Not Recruiting | 2026-05-13 |
| NCT06884293 | A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With… | Overweight | Active, Not Recruiting | 2026-05-12 |
| NCT05116462 | Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer | Non-Small Cell Lung Cancer | Active, Not Recruiting | 2025-06-26 |
| NCT05972473 | A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD | Neovascular Age-related Macular Degeneration | Active, Not Recruiting | 2025-03-13 |
| Phase 2 | ||||
| NCT06081920 | A Study of IBI363 in Subjects With Advanced Melanoma | Melanoma | Recruiting | 2026-07-29 |
| NCT07122687 | IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as… | Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer | Recruiting | 2026-07-27 |
| NCT07483554 | IBI343 in Combination Therapy for Advanced Malignant Solid Tumors | CLDN18.2 Positive | Recruiting | 2026-06-03 |
| NCT07483567 | IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of… | CLDN18.2 Positive | Recruiting | 2026-06-02 |
| NCT07330934 | A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe… | Atopic Dermatitis | Recruiting | 2026-03-11 |
| NCT07399067 | A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis | Atopic Dermatitis | Recruiting | 2026-02-13 |
| NCT06937749 | A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis… | Metabolic Dysfunction-associated Steatohepatitis (MASH) | Recruiting | 2025-11-20 |
| NCT06797297 | A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to… | Melanoma | Recruiting | 2025-04-04 |
| NCT06281678 | A Study of IBI363 in Subjects with Advanced Solid Malignancies | Melanoma | Recruiting | 2024-12-19 |
Lung Cancer (9) · Obesity (9) · Non-Small Cell Lung Cancer (NSCLC) (8) · Atopic Dermatitis (4) · Hypertension (3) · Melanoma (3) · Multiple Myeloma (3) · Colorectal Cancer (2) · NASH / MASH (2) · Ovarian Cancer (2)